People · Operator

Elizabeth G Kelley

Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals

1
Companies
1
Filings
$2.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Bridge Therapeutics, Inc.PharmaceuticalsSeed$2.3M$2.2M2019
Operator network

Elizabeth G Kelley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Christopher Patrick Palutis · 1 companies · 1 sharedChristopher Patri…David H Bergstrom · 1 companies · 1 sharedDavid H BergstromDiana H Harshbarger · 1 companies · 1 sharedDiana H Harshbarg…Elizabeth Gregory Kelley · 1 companies · 1 sharedElizabeth Gregory…James Gregory Sullivan · 1 companies · 1 sharedJames Gregory Sul…James G Sullivan · 1 companies · 1 sharedJames G SullivanJason Patrick Bailey · 1 companies · 1 sharedJason Patrick Bai…Joseph Patrick Mullin · 1 companies · 1 sharedJoseph Patrick Mu…Joseph S Mullin · 1 companies · 1 sharedJoseph S MullinKelley S Alton · 1 companies · 1 sharedKelley S AltonRussell G Kelley · 1 companies · 1 sharedRussell G KelleyTim G Peara · 1 companies · 1 sharedTim G PearaTimothy Grant Peara · 1 companies · 1 sharedTimothy Grant Pea…Bridge Therapeutics, Inc. · $2.3M raisedBridge Therapeutics, …Elizabeth G KelleyEK
Elizabeth G Kelley Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Elizabeth G Kelley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Christopher Patrick Palutis11
Joseph Patrick Mullin11
Elizabeth Gregory Kelley11
Jason Patrick Bailey11
Timothy Grant Peara11
James Gregory Sullivan11
Joseph S Mullin11
David H Bergstrom11
Tim G Peara11
James G Sullivan11
Russell G Kelley11
Diana H Harshbarger11
Kelley S Alton11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.